Performance and oncologic safety of sentinel lymph node biopsy after neoadjuvant chemotherapy: Results from a tertiary care center in Lebanon.
Mariam ZahweAya El SammakKarim AtayaChristelle JabbourAyman BsatBassel HafezChristine AtallahMira KheilMohamad Ali MaktabiBashar HassanVahe PanossianHazem I AssiJaber AbbasEman SbaityPublished in: Cancer medicine (2023)
The results suggest that in properly selected patients, SLNB can be feasible after NACT. Our results resemble the reported literature on accuracy of SLNB after NACT and adds to the growing pool of data on this topic.
Keyphrases
- neoadjuvant chemotherapy
- sentinel lymph node
- lymph node
- tertiary care
- end stage renal disease
- early stage
- locally advanced
- newly diagnosed
- systematic review
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- big data
- patient reported outcomes
- prostate cancer
- electronic health record
- radical prostatectomy
- minimally invasive
- data analysis